There are repeated indications that lymphatic dysfunction and loss of lymphatic VEGF-C signaling results in exacerbation of clinical findings of liver disease including portal hypertension and ascites (Kaur et al., 2021; Aboismail et al., 2022). This evidence concerns the gene VEGFC and Ascites.